Discussion of: "Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?"
Am J Surg
.
2017 Dec;214(6):1089-1090.
doi: 10.1016/j.amjsurg.2017.09.025.
Epub 2017 Sep 30.
Authors
Anees B Chagpar
1
,
Nina Horowitz
2
,
Tara Sanft
2
,
Lynn D Wilson
2
,
Andrea Silber
2
,
Brigid Killelea
2
,
Meena S Moran
2
,
Michael P DiGiovanna
2
,
Erin Hofstatter
2
,
Gina Chung
2
,
Lajos Pusztai
2
,
Donald R Lannin
2
Affiliations
1
Yale University School of Medicine, New Haven, CT, USA. Electronic address: anees.chagpar@yale.edu.
2
Yale University School of Medicine, New Haven, CT, USA.
PMID:
28987415
DOI:
10.1016/j.amjsurg.2017.09.025
No abstract available
Publication types
Comment
MeSH terms
Breast Neoplasms*
Chemotherapy, Adjuvant
Combined Modality Therapy
Female
Humans
Lymph Nodes*
Neoplasm Staging
Receptors, Estrogen
Substances
Receptors, Estrogen